#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7188	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1821	732.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1345	1345	C	884	C,G,A	559,3,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	7188	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1821	732.5	0	HET	.	.	.	A69G,C	.	69	69	A	230	230	A	670	A,G,C	139,292,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14264	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3548	757.6	0	.	n	.	0	T695C	SNP	695	695	T	1110	1110	C	991	C,A	626,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14264	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3548	757.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1752	1752	A	835	A,C,T	557,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14264	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3548	757.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2386	2386	C	697	C,A,T	460,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14264	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3548	757.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3012	3012	T	850	T,C,G	414,148,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	14264	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3548	757.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2460	2460	A	738	A	472	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	710	folP	855	855	100.0	folP.l15.c4.ctg.1	1567	85.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1017	1019	AGC	114;113;114	A;G;C,G	75;75;74,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3249	117.9	1	SNP	p	S91F	1	.	.	271	273	TTC	585	587	TTC	142;142;143	T,G,A;T;C,G	94,1,1;95;97,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3249	117.9	1	SNP	p	D95G	1	.	.	283	285	GGC	597	599	GGC	168;173;174	G;G;C,A	111;114;111,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2052	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3249	117.9	1	SNP	p	G95N	0	.	.	283	285	GGC	597	599	GGC	168;173;174	G;G;C,A	111;114;111,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	576	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1267	89.6	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	165;165;166	G;G;C	102;103;100	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	406	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1008	77.2	0	.	n	.	0	A197.	DEL	197	197	A	535	535	A	168	A	109	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1720	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3168	106.4	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	159;160;161	G,T;A;C	99,1;99;103	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1720	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3168	106.4	1	SNP	p	S87R	1	.	.	259	261	CGT	604	606	CGT	161;163;161	C;G,C;T	109;104,1;104	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1720	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3168	106.4	1	SNP	p	R87I	0	.	.	259	261	CGT	604	606	CGT	161;163;161	C;G,C;T	109;104,1;104	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1720	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3168	106.4	1	SNP	p	R87W	0	.	.	259	261	CGT	604	606	CGT	161;163;161	C;G,C;T	109;104,1;104	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1720	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3168	106.4	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	161;161;161	T;C,T;C	108;108,1;114	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1404	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2583	106.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1514	1516	GGC	83;83;83	G;G;C	60;59;58	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1190	1192	GCA	220;220;220	G;C,G,A;A	143;144,1,1;145	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1193	1195	ATC	221;221;221	A;T,G;C,A	146;145,1;146,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1205	1207	GTG	215;214;214	G,T;T;G	143,1;139;140	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1205	1207	GTG	215;214;214	G,T;T;G	143,1;139;140	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1709	1711	ACC	119;120;119	A;C,A;C,A	85;85,1;88,2	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1763	1765	GCG	97;97;97	G;C,A;G,C	70;67,1;67,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1763	1765	GCG	97;97;97	G;C,A;G,C	70;67,1;67,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1886	1888	AGC	120;122;128	A,C;G,T;C	88,2;90,1;96	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1895	1897	GGC	118;117;115	G,C;G,T;C,G	88,1;84,1;79,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2194	132.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1913	1915	CCG	118;112;112	C,G;C;GCCC,GCCCC	76,3;75;49,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	15	1578	penA	1752	136	100.0	penA.l6.c4.ctg.3	493	1.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	123	125	ACC	2;2;2	A;C;C	1;1;1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	283	2502	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3406	136.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1463	1465	GGC	106;106;106	G,C;G,A,T;C,G	71,2;73,2,1;68,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	886	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2019	84.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	601	601	C	68	C	39	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	913	915	AAT	13;13;13	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	916	918	AAT	13;13;12	A;A;T	8;8;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	940	942	GCA	9;9;9	G;C;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	963	965	GTA	8;8;8	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	S236N	NONSYN	706	708	AGC	969	971	AAC	8;8;8	A;A;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	N237M	NONSYN	709	711	AAC	972	974	ATG	8;8;8	A;T;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	284	90.62	porB1a.l6.c4.ctg.1	1172	11.2	0	.	p	.	0	D238fs	FSHIFT	712	712	G	975	975	G	8	G	5	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	795	780	porB1b	1035	1035	98.66	porB1b.l6.c30.ctg.1	1731	82.6	0	.	p	.	0	E48K	NONSYN	142	144	GAA	1201	1203	TCA	114;114;114	T;C;A,C	79;79;78,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	795	780	porB1b	1035	1035	98.66	porB1b.l6.c30.ctg.1	1731	82.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	712	712	A	105	A,T,C	73,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	795	780	porB1b	1035	1035	98.66	porB1b.l6.c30.ctg.1	1731	82.6	1	SNP	p	G120K	0	.	.	358	360	GGT	983	985	CCA	84;88;88	C;C,T;A	56;59,1;59	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	795	780	porB1b	1035	1035	98.66	porB1b.l6.c30.ctg.1	1731	82.6	1	SNP	p	A121D	0	.	.	361	363	GCC	980	982	CGG	89;89;89	C;G;G	61;62;62	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	795	780	porB1b	1035	1035	98.66	porB1b.l6.c30.ctg.1	1731	82.6	1	SNP	p	A121N	0	.	.	361	363	GCC	980	982	CGG	89;89;89	C;G;G	61;62;62	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3426	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5074	130.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	252	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1400	36.6	1	SNP	p	V57M	1	.	.	169	171	ATG	688	690	ATG	96;91;98	A;T;G	61;58;62	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
